At a glance
ClinicalIndex Comparison Record- ✓Over 18 years old
- ✓Diagnosed with Major Depressive Disorder, Bipolar Depression, Generalized Anxiety Disorder, OCD, or Eating Disorder by a licensed healthcare practitioner
- ✓Significant history of trauma and/or formal diagnosis of PTSD per DSM 5
- ✓Psychologically and medically cleared by psychiatrist, family physician, or treatment team
- ✕Unable to consent to treatment
- ✕Pregnant women and nursing mothers (postpartum depression considered case-by-case)
- ✕Substance Use Disorder meeting DSM 5 criteria in past 3 months; alcohol/opioid/benzodiazepine/cocaine/amphetamine use disorders require detox and 4-week sobriety
- ✕Daily use of moderate to high doses of benzodiazepines
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective Review of Ketamine Assisted Psychotherapy Program on Mental Health at Field Trip Health Centres in North America
In Brief
A Phase 4 clinical trial evaluating Ketamine-Assisted Psychotherapy (KAP) for Depression and 2 related conditions. Completed, enrolled 1,806 participants across 11 sites in 2 countries.
Detailed Summary
Ketamine-Assisted Psychotherapy (KAP) is a relatively new approach for the treatment of mental health issues, which involves the combination of ketamine, a dissociative anaesthetic with psychedelic properties, and psychotherapy to promote emotional wellbeing. In this study, we investigated the effectiveness of KAP in adult patients coping with mental health. We predicted that clients would experience lasting reductions in psychological distress over time, such as depression, anxiety, and post traumatic stress, that would be detectable up to 6 months after treatment. The results of this study may provide evidence of sustained real-world effects of Ketamine-Assisted Psychotherapy, of interest to patients, clinicians, researchers, and policymakers.
Study Details
Timeline
Interventions
KAP consisting of 4-6 guided ketamine sessions with psychotherapy-only visits after dose 1 and 2 and then after every 2 subsequent doses.